DNM1P48

Across TCGA pan-cancer cohorts, DNM1P48 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated DNM1P48 data layer.

The strongest signal is observed in sarcoma (SARC), where higher DNM1P48 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNM1P48 expression acts as an unfavorable survival marker.

SARC and PRAD are the cancer types where DNM1P48 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Tertile	All	0.096	0.611	.005	18	view →
PRAD	DFS	Tertile	All	0.106	0.774	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DNM1P48–SARC (DFS)

Open the SARC breakdown →